EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:758302 - olpasiran
| ChEBI ID | CHEBI:758302 |
| ChEBI Name | olpasiran |
| Stars | |
| Last Modified | 30 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Applications: | cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. renoprotective agent Any compound that is able to prevent damage to the kidneys. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| olpasiran (CHEBI:758302) has role antiatherosclerotic agent (CHEBI:145947) |
| olpasiran (CHEBI:758302) has role cardiovascular drug (CHEBI:35554) |
| olpasiran (CHEBI:758302) has role renoprotective agent (CHEBI:231911) |
| olpasiran (CHEBI:758302) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| olpasiran | WHO MedNet |
| Synonyms | Source |
|---|---|
| AMG 890 | ChEMBL |
| AMG-890 | ChEMBL |